Join us for a panel discussion during our Access Insights Conference exploring the financial implications of market access in healthcare. Panelists, Lance Wilkes, Jim Meyers, Cynthia (Cyndi) Goss, Jose Luis Valdes, and moderator Reena Patel will discuss regulatory changes, payer strategies, and real-world market access challenges. Don’t miss this opportunity to gain insights into the future of the industry. Register today: https://lnkd.in/eYB8irsw
IntegriChain
Technology, Information and Internet
Philadelphia, PA 80,016 followers
Data-Driven Commercialization
About us
IntegriChain is the leading provider of revenue optimization technology and insights for the Pharma industry. The company’s ICyte data-driven commercialization platform enables manufacturers to develop, implement, and operate sustainable growth strategies for life-changing science. Through its unique focus on data, SaaS and BPaaS technology, consulting, and outsourcing, IntegriChain helps manufacturers connect the commercial, financial, and operational dimensions of drug access – all the way from demand through to net revenue optimization. IntegriChain is backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Technology. IntegriChain’s umbrella of companies include Blue Fin Group and Federal Compliance Solutions, and the company is headquartered in Philadelphia, PA, with offices in Ambler, PA, and Pune, India.
- Website
-
https://www.integrichain.com
External link for IntegriChain
- Industry
- Technology, Information and Internet
- Company size
- 501-1,000 employees
- Headquarters
- Philadelphia, PA
- Type
- Privately Held
- Founded
- 2005
- Specialties
- Life Sciences Channel Data and Analytics, Pharmaceutical Commercial Data Analytics, Business Intelligence, Advanced Analytics, Distribution Analytics, Patient Access, Market Access, Specialty Pharmaceuticals Analytics, Payer Analytics, Access Management, Government Pricing, Rebate Processing, Patient Services, Channel Data Aggregation, Inventory Analytics, Pharma Access, Pharma Distribution, Pharma Distribution Management, Master Data Management, Data Science, Gross to net automation, Commercial data warehouse, pharma commercialization, advisory services, strategy consulting, and trade and channel
Products
IntegriChain ICyte Platform
Pharmacy Management Systems
IntegriChain helps Pharma manufacturers bring their science to market, ensuring patients have affordable, timely, and sustainable access to therapy. We are doing this by building Pharma’s data-driven commercialization platform – from strategy to operational execution. Our unique focus on data, technology, consulting, and outsourcing helps connect the commercial, financial, and operational dimensions of drug access and profitability. IntegriChain enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing daily and recurring business activities and by integrating data and operations across contracting, pricing, channel and distribution, and gross-to-net.
Locations
-
Primary
8 Penn Center
1628 JFK Boulevard
Philadelphia, PA 19103, US
-
201 S Maple St
Ambler, Pennsylvania 19002, US
-
Pancard Club Rd
M Agile, Samarth Colony
Baner Pune, Maharashtra 411045, IN
Employees at IntegriChain
-
Gary Palgon, CISSP
Sales. Marketing and Operations Executive; Healthcare/Life Sciences; Analytics/Security/Cloud
-
Michael Kerman
Marketing and Technology Executive | Revenue Generator | Talent Developer
-
David Weiss
-
Vickie Kozhushchenko
CHRO, delivering HR Strategy, Peer & Leadership Coaching, Org Dynamics and Transformation. I bring strategic HR thinking to private equity-backed…
Updates
-
IntegriChain is proud to be a sponsor of this year’s Medicaid Drug Rebate Program (MDRP) event. Jake Keenan will discuss how pharmaceutical manufacturers can navigate the complexities of the Inflation Reduction Act. He'll cover new rebate requirements, refunds for discarded drugs, and necessary system adjustments for efficient compliance. Learn more: https://lnkd.in/dfJQ7AqD
-
The healthcare landscape is changing rapidly. Join Jeffrey Baab on October 15 at 9:05AM during our Access Insights Conference to learn how market events and policy changes are impacting pricing, contracting, and market access decisions. Register today: https://lnkd.in/eYB8irsw
-
Join Reena Patel and KerriAnne Fortier during their Navigating Pre-Commercialization Decisions in Pharma/Biotech session on October 15 at 2:15PM. Whether you’re a startup founder, business development executive, or a seasoned professional in the biotech space, this session will provide you with the tools and knowledge needed to navigate the complex pre-commercialization landscape with confidence. Register today: https://lnkd.in/eYB8irsw
-
Looking to tap into the growing cash-pay market? Our final webinar tomorrow led by Daniel Landis, Dan DiGiorno, and Rich Prest will equip you with the tools and knowledge to maximize manufacturer support, identify high-demand products, and build a profitable cash-pay program. Register now: https://lnkd.in/eKYaaBwW
-
A huge round of applause for our incredible employees celebrating their work anniversaries 🎊 1 YEAR Devansh Vyas, Vishal Patil, Ankit Jaiswal, Priti Gaikwad, Senthil Indran, Shubham Shirse, Kiran Kulkarni, Senthil Indran, John Griebel, Lerence Melton, Carmen Parker-Mayers, Brendan Ellis, Ambika Prabhat 2 YEARS Akash Shirude, Sushil Kumar, Sumit Pandey, Poonam Darekar, Jyotika Arora, Jason Shapiro, Nilsson Lopez, CFA, Dan DiGiorno, Nick Iaconi, Brandy Jensen, MSC 3 YEARS Arpit Goyal, Jaydeep Bhadane, Kalyani Bhansali, Kaushik Patra, Milina Salvi, Shubham Jarode, Somya Pradhan, Swati Bhide, Vandana Bhatt, Ritika Sriwastav, Vinit Dhamapurkar, Samidha Rawool, Sarnab Sen Gupta, Abhinandan Jain, Balkrishna Devar, Vidushi Chouhan, Scott Gephart, Trish Booth, Amy Patterson, Ed Gazarkh, MBA, Aditya Katragadda, Darren Schneider, Brittany Sulpizio 4 YEARS Octavio O.-Caamano, Robbi Bunten, Linda Williams, Shermeeka Brailsford, Elizabeth Head, Jane Edwards 5 YEARS Tracy Creach 6 YEARS Gary Palgon, CISSP 7 YEARS Vaibhaosingh Chavan, Hector Narvaez, Tara Booke, Aswini Kusalakumar, Neeraja Pushpanathan, Vickie Bruno, CPA 8 YEARS Rohit Ahire 10 YEARS Setu Prasad We are incredibly grateful for your dedication, passion, and talent. You are the backbone of our success, and your contributions don't go unnoticed. Thank you for choosing to be part of the IntegriChain journey. Here's to many more years of making a difference together!
-
Christine DiPretore is a valued member of our Managed Care Operations team! She’s a results-driven Finance professional who provides investigational analysis and problem-solving across many teams at IntegriChain. She’s a shining star and creates a positive environment as she strives to deliver the highest quality work to our customers. If you're seeking to be part of a team that values its members, explore our career opportunities here: https://lnkd.in/d6B_eKm
-
Join us for a must-attend expert panel at our Access Insights Conference. Hear from industry experts Chris Mancill, John Robicsek, Thomas Cohn, and Rich Prest as they delve into the complexities of delivering products to patients. Learn how manufacturers can navigate the evolving healthcare landscape, adapting to changes in regulations, payer policies, and distribution channels. Don't miss this opportunity to gain valuable insights and stay ahead of the curve. Register today: https://lnkd.in/eYB8irsw
-
This month Katie Herrick, Principal Consultant, and Daniel Landis, Senior Consultant, respectively at Blue Fin Group, an IntegriChain Company, share how pharmaceutical companies are adapting to the evolving healthcare landscape by prioritizing patient access and affordability. Learn more: https://lnkd.in/edPUHq5r
-
Don't miss our expert insights at the Medicaid Drug Rebate Program Summit. IntegriChain is a proud sponsor, and we'll be sharing valuable information on IRA negotiation best practices. Hear from Jeffrey Baab at 10:55 AM on September 24th, and catch Jake Keenan in the Nuts and Bolts panel discussion at 2:50 PM for expert insights on pricing and the IRA. Learn more: https://lnkd.in/dfJQ7AqD